根据最终合并协议,Viewpoint的每一股已发行和流通股份将转换为获得Isoray 3.3212股的权利。Viewpoint股东将拥有Isoray完全稀释的流通股49%的股份。
$华海药业(SH600521)$ $华东医药(SZ000963...查看全文
$IsoRay, Inc.(ISR)$ DEF 14A - Other definitive proxy statements Filed: 2017-11-03 AccNo: 0001437749-17-018279 Size: 922 KB 网页链接
$IsoRay, Inc.(ISR)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-11-03 AccNo: 0001437749-17-018280 Size: 414 KB 网页链接
$IsoRay, Inc.(ISR)$ DEF 14A - Other definitive proxy statements Filed: 2017-11-03 AccNo: 0001437749-17-018279 Size: 922 KB 网页链接
$IsoRay, Inc.(ISR)$ 8-K - Current report Filed: 2017-10-27 AccNo: 0001437749-17-017751 Size: 38 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$IsoRay, Inc.(ISR)$ 8-K - Current report Filed: 2017-10-10 AccNo: 0001144204-17-051884 Size: 84 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$IsoRay, Inc.(ISR)$ 8-K - Current report Filed: 2017-09-28 AccNo: 0001144204-17-050438 Size: 155 KBItem 2.02: Results of Operations and Financial ConditionItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$IsoRay, Inc.(ISR)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2017-09-28 AccNo: 0001144204-17-050344 Size: 6 MB 网页链接
$IsoRay, Inc.(ISR)$ 8-K - Current report Filed: 2017-08-31 AccNo: 0001144204-17-046050 Size: 304 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$IsoRay, Inc.(ISR)$ 8-K - Current report Filed: 2017-08-31 AccNo: 0001144204-17-046050 Size: 304 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$IsoRay, Inc.(ISR)$ 8-K - Current report Filed: 2017-07-07 AccNo: 0001144204-17-036091 Size: 123 KBItem 1.01: Entry into a Material Definitive AgreementItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory ...